Zymeworks (ZYME) Change in Receivables (2021 - 2026)
Zymeworks recorded quarterly Change in Receivables of $36000.0 in Q1 2026, up 100.15% quarter-over-quarter from -$24.7 million in Q4 2025, and up 100.12% year-over-year from $17989.6 in Q1 2025.
Zymeworks' Change in Receivables history runs 6 years deep, the most recent figure standing at $36000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 100.12% year-over-year to $36000.0; the TTM figure through Mar 2026 stood at -$19.9 million (down 215.19% YoY), while the FY2025 annual figure was -$51.2 million, down 240.82% from the prior year.
- Change in Receivables came in at $36000.0 for Q1 2026 at Zymeworks, up from -$24.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $33.5 million in Q1 2023 to a low of -$47.8 million in Q4 2023.
- A 5-year average of -$659882.4 and a median of $36000.0 in 2026 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 697.92% in 2023 and fell as far as 11886.09% in 2023.
- Zymeworks' Change in Receivables stood at $26.7 million in 2022, then sank by 279.2% to -$47.8 million in 2023, then surged by 166.18% to $31.6 million in 2024, then tumbled by 178.13% to -$24.7 million in 2025, then surged by 100.15% to $36000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $36000.0, -$24.7 million, and $26.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | -24.71 Mn |
| Dec 31, 2025 | -24.71 Mn |
| Sep 30, 2025 | 26.72 Mn |
| Sep 30, 2025 | 26.72 Mn |
| Jun 30, 2025 | -21.99 Mn |
| Jun 30, 2025 | -21.99 Mn |
| Mar 31, 2025 | -31.22 Mn |
| Mar 31, 2025 | -31.22 Mn |
| Dec 31, 2024 | 31.63 Mn |
| Dec 31, 2024 | 31.63 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 11.47 Mn |
| Mar 31, 2024 | 11.47 Mn |
| Dec 31, 2023 | -47.80 Mn |
| Dec 31, 2023 | -47.80 Mn |
| Sep 30, 2023 | 18.46 Mn |
| Sep 30, 2023 | 18.46 Mn |
| Jun 30, 2023 | -18.10 Mn |
| Jun 30, 2023 | -18.10 Mn |
| Mar 31, 2023 | 33.52 Mn |
| Mar 31, 2023 | 33.52 Mn |
| Dec 31, 2022 | 26.67 Mn |
| Dec 31, 2022 | 26.67 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | -151,000.00 |
| Jun 30, 2022 | -151,000.00 |
| Mar 31, 2022 | -11.33 Mn |
| Mar 31, 2022 | -11.33 Mn |
| Dec 31, 2021 | 10.69 Mn |
| Dec 31, 2021 | 10.69 Mn |